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ABSTRACT
PurPose: High prevalence of colon carcinoma explains the continued high mortality rate of this disease. 
utilizing a strategy of virtual colonoscopy (VC) in patients aged over 50 years with optical colonoscopy (oC) 
following-up for removal of detected adenomatous polyps may result in lowering the colon cancer death 
rate. However, VC diagnostic potential has not been widely recognized yet.
MATerIAl ANd MeTHods: This article reviews the currently available in diagnostic options in colorec-
tal neoplasms and discusses their advantages and drawbacks. 
resulTs: VC has many advantages over the existing options and its several drawbacks can be mitigat-
ed so that it would become a valuable diagnostic modality. A strategy that utilizes VC for screening of pa-
tients over the age of 50 years and oC for screening high-risk individuals and those with positive VC find-
ings would result in a significantly reduced colon cancer mortality rate.
CoNClusIoN: Both oC and VC (i.e., CTC and MrC) progress toward the clinical needs as new technolo-
gies are developed and applied to overcome the drawbacks of these diagnostic methods. each of them plays 
a unique role for colon cancer prevention.
Key words: optical colonoscopy, virtual colonoscopy, computed-tomography colonography, colon cancer, 
diagnosis
INTRODuCTION
Colorectal carcinoma (CRC) is the third most 
commonly diagnosed cancer and the second leading 
cause of death from cancer in the world (1,2). Simi-
lar to other cancers, it is often diagnosed at advanced 
stage, after the patient has developed symptoms. Dif-
ferent from many cancers, colon cancer can be pre-
vented by detection and removal of its precursor le-
sion, the adenomatous polyp. Colon cancer is ame-
nable to screening because of the long-time inter-
val (approximately 10 years) of adenoma-carcino-
ma sequence. For example, it takes more than two 
years for an adenomatous polyp to grow up to 5 mm 
in size with far less than 1% cancer risk, addition-
al three or more years to 10 mm in size with cancer 
risk approaching to 1%, and other five or more years 
to 20 mm in size and 10% cancer risk (3). Therefore, 
screening of an asymptomatic patient at an adequate 
time interval and removal of detected adenomatous 
polyps of less than 10 mm in size can effectively re-
duce the likelihood of cancer development (12,13). 
Small colorectal adenomas measuring between 6 and 
9 mm should not be ignored, in order to decrease 
CRC prevalence rate (19).
Fecal occult blood testing (FoBT) is, probably, 
the easiest method for screening the fatal disease. 
It can be performed at home by collecting stool 
samples without bowel preparation and complication 
and delivering the samples to a service laboratory. 
Conceptually, FoBT is highly sensitive. However, it 
detects only 30-40% of CRC and 10% of adenomas 
at late stage of the malignant transformation with 
specificity ranging from 88% to 98% (20). This 
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screening option is currently recommended annually 
for asymptomatic patients. This test can reduce 
cancer mortality rate by 15-33% (3). Recently, stool 
DNA testing shows a wide sensitivity range from 52% 
to 91% and specificity ranging from 93% to 97% at a 
late stage of the malignant transformation, too (3). It 
costs more than FIT. While their sensitivities can be 
improved by adequately taking the stool samples as 
detailed elsewhere (3), these three screening methods 
share the same limitation of detection at advanced 
stage of the malignant transformation. In addition, 
their detection does not provide the location 
information where the malignant transformation 
occurs. Complete bowel preparation involves 
significant invasiveness and is essential for an 
optimal examination. The risk of bowel perforation 
is rare, about 1 in 25000 cases. It can have therapeutic 
capability of resecting the diagnosed polyps and 
removing the rest abnormalities, but it fails to detect 
polyps in the proximal colon, where 40% of all the 
cancers occur, and misses up to 10-15% of sigmoid 
colon carcinomas (4). The risk of bowel perforation is 
rare, less than 1 in 20000 cases.
OPTICAL COLONOSCOPY
Since the first reported complete examination 
of the colon using a flexible fiberoptic endoscope 
by Wolff and Shinya in 1971 (cited after 2), oC has 
evolved to be the current gold standard for evaluation 
of the entire colonic mucosal surface with therapeutic 
capability of resecting the detected lesions. Prior to 
oC, the patient must undergo bowel preparation 
usually consisting of (i) taking clear liquid diet and 
(ii) ingesting purgative solutions for colon cleansing 
the day before examination. Sedation is commonly 
used to relieve the discomfort during the procedure 
and, therefore, an escort is needed to accompany the 
patient to home. The modern colonoscope is equipped 
with a charge-coupled device or camera and four-
way tip controls (3). The camera can produce images 
of high-definition television quality with zoom or 
magnification capability. The four-way tip controls 
include (i) interrogating a found patch to confirm 
an abnormal growth if it cannot be pushed away, 
(ii) insufflating air to extend the lumen for mucosal 
inspection and relieving air after inspection, (iii) 
irrigating a concerned region, (iv) sucking to avoid 
missing lesions under fluid, and (v) inserting biopsy 
or polypectomy snare devices. Currently, oC is the 
definitive test in following-up the positive findings 
of the above screening options, i.e., FoBT, FIT, 
stool DNA testing, DCBE, FS, and other imaging 
modalities. In addition, it is also the most common 
choice of evaluating a variety of signs and symptoms 
such as (i) unexplained gastrointestinal bleeding or 
iron deficiency anemia, (ii) chronic inflammatory 
bowel disease, (iii) significant diarrhea of unexplained 
origin, (iv) abdominal pain, etc. It is also the most 
common modality of performing interventions 
such as hemostasis, polypectomy, foreign body 
removal, balloon dilation, palliative treatment of 
neoplasms, etc. (4). The current practice of oC is to 
attempt removal of any detected polyps, regardless of 
histology (adenomatous or hyperplastic). 
A reduced incidence rate of colon cancer 
from 76% to 90% would be expected by the use of 
oC procedures every 10 years if no findings and 
shorter time intervals of abnormalities are found 
and therapeutic actions are performed (4). While it 
is accurate, oC has several drawbacks as a screening 
option: (i) it is an invasive procedure and sedation 
may be needed. Sedation use requires an escort, 
increases the costs and may induce complications 
such as cardiac arrhythmias, hypotension, oxygen 
desaturation, etc. (4,5); (ii) bowel preparation prior 
to the procedure is stressful, requiring a full oral 
laxative colon cleansing, and may cause abdominal 
discomfort, cramps, nausea, and other symptoms 
(3); (iii) oC is time-consuming (especially for elder ly 
patients), ranging from 30 minutes to an hour; (iv) it 
carries a small risk of perforation and death - colonic 
perforation in one of about 1000 cases and death in 
one of about 5000 cases (1). It may fail to demonstrate 
the entire colon in 10-15% of cases and may miss up 
to 10-20% of polyps <1 cm (11). overall, the missing 
rate of oC for large adenomas and cancer is about 
12% and 5%, respectively (3). For the asymptomatic 
patient population aged over 50 years, where the 
prevalence of polyps ranging from 6 to 9 mm would be 
8-9% and polyps of 10 mm and larger would be 5-7% 
(4), screening oC would be expected to be normal in 
more than 80% of cases. The risk and cost on these 
normal cases would be unnecessary. Furthermore, 
it would be expected that of the 16-20% of cases in 
which a polyp is found out, only one third would be 
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true adenomas and the other two-thirds would be 
hyperplastic lesions (6). The resection of these other 
hyperplastic polyps by current oC practice may not 
be necessary.
For patients with non-specific gastrointestinal 
symptoms, such as anemia and change in stool 
habits, oC may find polyps of size 10 mm or greater 
in about 7% (slightly higher than the findings in the 
asymptomatic patient population aged over 50 years) 
as compared to 17% in patients with a positive FoBT 
(2). Therefore, the safe and least expensive screening 
options of FoBT, FIT and stool DNA testing may 
be of benefit for the patients with non-specific 
gastrointestinal symptoms prior to oC procedure 
application. With further technology development, 
oC can improve its performance as a screening tool, 
but it could not be an optimal option to screen the 
entire targeted population due to: (i) the drawbacks 
associated with oC (e.g., more than 80% of the 
screened subjects would be negative because the 
prevalence of polyps is less than 20% in the population 
(10), (ii) the risk of sedation and perforation, (iii) the 
cost including an escort, (iv) the costs associated with 
unnecessarily removing the hyperplastic polyps (14), 
and (v) the lack of resources as it could take many 
years and great efforts to train a sufficient number of 
oC operators to perform the screening task (12,13). 
Because of the high prevalence of the disease and 
the low compliance rate to the currently available 
screening options, CRC mortality rate remains high. 
A more effective screening method as compared to 
the above mentioned options for evaluation of the 
entire colon and detection of polyps as small as 5 
mm is desired. To that end, a great research effort 
has been seen in the past decades in searching for 
such an alternative. Developing virtual colonoscopy 
(VC) to supplement the screening role of oC is one 
example of these research efforts.
VIRTuAL COLONOSCOPY
Since 1994 onwards, several pilot studies (12) 
evaluating the feasibility of an alternative means using 
computed tomography (CT) imaging technology for 
the purpose of screening the entire colon motivate 
a substantial research interests ranging from image 
formation and segmentation to visualization (13), 
although there is already an earlier report (12). This 
alternative means, i.e., CT-based virtual colonoscopy 
or CT colonography (CTC), utilizes computer 
virtual-reality techniques to navigate inside a three-
dimensional (3D) patient-specific colon model 
reconstructed from abdominal CT images looking 
for polyps. It starts by inflating the cleansed colon 
by room air or Co2 introduced through rectal insert 
tube (11). Then abdominal CT slice images are taken 
in seconds (during a single breath holding) with sub-
milimetre resolution in both axial and transverse 
directions and good image contrast between the 
colon wall and the lumen filled by air/Co2. The 
slice images are stacked together as a volume image, 
from which the colon model is constructed. Image 
segmentation is necessary for the construction of 
an accurate colon model (7). Computer graphics are 
heavily involved to navigate or fly through inside the 
3D colon model (9). For the purpose of validating 
the detection in the 3D colon model, interpretation 
of the 2D image slices at the three orthogonal (i.e., 
transverse, sagittal and coronal) directions is often 
included in the VC procedure. 
Initial clinical trials on the concept of CTC using 
laboratory prototypes show satisfactory sensitivity 
and specificity compared to the clinical oC (7). 
Significant improvement is later on demonstrated 
by large clinical trials using commercially available 
CTC systems. one example is the DoD clinical trial 
on 1233 asymptomatic patients using the commercial 
V3D Colon Module system (7). A sensitivity of 93,9% 
and specificity of 92,2% is achieved versus oC 
sensitivity of 91,5% for polyps of 8 mm and larger by 
the same bowel preparation and same day operation 
of CTC and oC. other examples are the more recent 
ACRIN trial (7) and IMPACT trial (9), which include 
a wider range of subjects, radiologist’s experience 
and CT/CTC systems and generate similar results 
for polyps of 10 mm and larger. The results of these 
studies indicate that by a similar full oral bowel 
cleansing, both CTC and oC have a comparable 
performance for detecting the polyps of 10 mm and 
larger and thus CTC can be a potential screening 
tool to supplement oC for CRC prevention. Current 
CT scanning for VC procedure is usually operated 
at a mAs level over 100 and delivers a significant 
amount of x-ray radiation exposure (two to four rads 
of dosage) to patient’s abdomen (9). In comparison, a 
routine x-ray chest radiograph (or x-ray film) delivers 
approximately 0,5 rads of radiation exposures. For 
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screening purpose, the radiation to the population 
would be excessively high and could increase the risk 
of getting cancer and other diseases (12). Despite the 
hardware optimization and software improvement 
for CT advancement in the past decades, the concern 
on the CT-associated radiation risk remains. Given 
the current CT technologies, a simple and effective 
strategy to further reduce the radiation would be 
to lower the mAs level (i.e., delivering less x-ray 
photons to the body) during data acquisition (3). 
Despite the great effort on this solution in the past 
decade (11), CTC still faces challenges at a mAs level 
lower than 50. Given the clinical task of detecting 
the polyps as small as 5 mm, the goal of further 
research is to achieve the lowest mAs level on the 
most recent CT systems. An alternative solution to 
minimize the radiation is to use magnetic resonance 
imaging (MRI) instead of CT for the VC procedure, 
i.e., MR colonography (MRC). However, this MRC 
alternative solution has several limitation compared 
to CTC. It is more costly, more sensitive to motion 
and other artifacts, and has lower spatial resolution 
(8). Compared to other imaging modalities, low-dose 
CT and high performance MRI are the two most 
attractive imaging modalities for VC. 
Great research efforts are devoted to advance 
CTC and MRC, especially CTC, toward a viable 
screening option. Regarding the issue of detection 
of small polyps, current modern CT can reach 
sub-millimetre spatial resolution and acquire a 
volumetric image of the abdomen in a single breath-
holding time period. By theory, the achieved sub-
millimetre spatial resolution could resolve polyps 
protruding to the colon lumen by a size as small as 
a couple of millimetres. In practice, the missing of 
polyps greater than 5 mm is common in the hands 
of experts with current CTC system (6). A major 
reason for the cause may be due to the imperfect 
colon cleansing and air/Co2 inflation. They will not 
generate a perfect interface between the colon wall 
and the air/Co2-filled lumen for detection of polyps 
at the CT spatial resolution. The complexity of colon 
anatomical structure may add more difficulties for 
the detection. For example, a small polyp could 
be highly likely missing the detection when it is 
located at the sharp turn of the colon or at the root 
of a colon folder. Another major reason for missing 
polyp detection can be the loss of image information 
by the post-image processing algorithms in 
current CTC systems (e.g., segmentation for the 
colon lumen, construction of the colon model, 
incomplete coverage of the entire colon mucosa 
surface in endoscopic views, etc.). There are recent 
improvements in these aspects and more details 
are given below. Because of the similarity in x-ray 
attenuation among colonic fluid, stool and colon 
wall, it is almost impossible in the CT images to find 
a polyp submerged inside the residue fluid (after 
a routine full oral bowel cleansing). To avoid this 
problem, the patient is scanned at both supine and 
prone positions. It is hoped that the residue colonic 
materials will fall to another side when the patient is 
turned from one position to another while the polyp 
remains at the same location. Unfortunately, this 
is frequently not the case due to many reasons (11). 
Clear fluid may move, but some sticky residual stool/
fluid may not. The use of two CT scans doubles the 
radiation. An alternative solution is to tag the colonic 
materials for enhanced image contrast between the 
colonic materials and the colon wall and to use 
computer algorithms to virtually cleanse the colon, 
called virtual or electronic colon cleansing (ECC) 
(18). It includes three major components of (i) image 
intensity alteration by oral fecal tagging, (ii) image 
segmentation for classifying the tagged image voxels, 
and (iii) postsegmentation operation for cleansing 
the colon lumen or extracting the colon wall. This 
alternative solution is a major contribution to the high 
CTC performance (12), where the scans at supine and 
prone positions are taken and the routine cathartic 
bowel preparation of oC is adapted and so, the 
ECC works on the residual colonic materials. Since 
it works for virtual cleansing of the residues after 
the routine cathartic bowel preparation, ECC shall 
also work on virtual cleansing of any fecal materials 
without the routine cathartic bowel cleansing, 
leading to cathartic-free CTC - a substantial relief 
of the bowel preparation stress of the current CTC 
practice. In addition, if ECC works on one of the 
two scans, the other scan may not be needed and, 
therefore, the radiation can be reduced by a half. 
If cathartic-free CTC is available, the patient may 
choose the less-stressful screening procedure first, 
and only those patients who present with clinically 
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significant polyps will undergo the oC intervention 
after the stressful cathartic bowel preparation. 
Further development of ECC for single CT scan 
and cathartic-free CTC would depend on powerful 
image segmentation and feature extraction. Because 
of the enhanced image intensities, there are several 
challenges associated with the alternative ECC 
solution, e.g., the presence of partial volume (PV) 
effect at the interface between the colon wall and 
the fecal materials with non-uniformly enhanced 
image intensities. The PV effect blurs the interface 
over a variable range as wide as several image voxels 
depending on the surrounding the image contrast, 
causes the loss of details about the interface and, 
therefore, results in the missed detection of small 
polyps. The PV effect and the non-uniformly altered 
image intensity distribution must be handled by the 
ECC algorithms (11). Differentiation of the colonic 
materials from the colon wall/polyps could also be 
made by the use of dual energy scans of a modern 
CT device (e.g., a dual x-ray source scanner). 
Despite the increased x-ray radiation to the patient 
by dual energy scans, this alternative approach for 
image contrast may be worthy for investigation. 
With accurate handling of the PV effect and the 
non-uniformly altered image intensity distribution 
via improved image segmentation, the innovative 
ECC strategy should further reduce the risk from 
x-ray radiation, mitigate the challenge in detecting 
the small polyps, and relieve the stress on the bowel 
preparation toward cathartic-free CTC. While 
constructing the accurate colon model from an 
ECC-cleansed colon lumen of an abdominal volume 
image for inspection of the entire colon inner 
surface possibly achieved by the commercial V3D 
Colon Module (8), searching for abnormalities and 
identifying the polyps along the long colon ‘pipe’ 
would be a challenge task because of the involved 
intensive user interaction during the fly-through 
navigation. In addition, the variation among 
readers with different experience is widely noticed. 
Conceptually computer-aided detection (CAD) can 
reduce the readers’ interaction effort and minimize 
the variation among readers’ assessments. However, 
a series of recent studies turns out that developing 
an effective CAD system is very challenging (13) 
because of many causes of false positives (FPs) such 
as imperfect bowel cleansing, complicated colon 
fold structures, image noise, motion artifacts, etc. 
Based on our experience in the field, surface-
based CAD as reported in most previous CAD 
papers is not sufficient to reduce the FPs to an 
accepted level (e.g., <10 per patient). Morphological 
and texture features beyond the inner surface inside 
the mucosal layer and probably even inside the colon 
wall are needed (16). High sensitivity CAD with 
minimal number of FPs remains an active research 
topic. Recent development of various texture features 
of the image intensity distribution and virtual biopsy 
features of the image intensity projection from the 
colon wall shows promise for high performance 
CAD (17).
DISCuSSION
Because of the high colon carcinoma prevalence, 
screening of asymptomatic patients to detect and 
remove adenomatous polyps is an effective strategy 
to reduce the mortality rate. However, the screening 
options currently available have their limitations 
and offer a suboptimal solution. While effective 
for detecting polyps, oC would consume a great 
deal of resource if American Cancer Society (ACS) 
guidelines are applied to the target population. 
It is unlikely that oC will be able to single out 
asymptomatic patients with adenomatous polyps. 
Compared to other screening options, VC has the 
potential to identify patients with adenomatous 
polyps for colonoscopy. The combination of VC 
screening with oC follow-up could be a cost-
effective means to prevent the fatal disease. However, 
there are several challenges in developing VC to 
accomplish this task. With CT-based VC or CTC, 
the associated radiation is a concern. Differentiation 
of the colonic materials from the colon wall remains 
a great challenge. While MRI-based VC or MRC 
alleviates the radiation concern and is more capable 
of differentiating the colonic materials from the colon 
wall with the potential to obtain more image contrast 
inside the colon wall, it possesses a lower spatial 
resolution and is prone to motion artifacts. Both 
CTC and MRC need sophisticated image processing 
operations to construct the colon model and perform 
real-time fly-through inside the model when looking 
for abnormalities. Sophisticated image processing 
operations would be more essential if differentiation 
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of adenomatous polyps from hyperplastic ones is 
desired. In other words, the extraction of the colon 
wall volume via the ECC innovation (9) and the 
analysis of texture features from image intensity 
of the wall (7) would be the key steps toward 
computer-aided detection and diagnosis. If the colon 
wall volume, rather than only the inner mucosa 
surface of the wall, can be accurately extracted by a 
sophisticated ECC pipeline, then almost the entire 
clinically desired information can be obtained. From 
the extracted wall volume, we can analyze both 
geometric and image-density textural information 
for early signs of abnormality (12). This will improve 
not only the current VC detection capability of small 
polyps protruding into the lumen space, but also 
the detection of flat polyps which cause the wall 
thickening, rather than protruding into the lumen, 
and render an extremely challenging detection 
task (11). Taking CTC as an example, the strategy 
of lowering the mAs level during data acquisition 
and utilizing the statistical methods for image 
reconstruction is an innovation to reduce the risk 
of radiation (13-15). Furthermore, application of a 
statistical restoration algorithm to estimate the line 
integrals or radon transform of the CT attenuation 
distribution and inverting the radon transform for 
the CT image is another innovation to overcome the 
challenge of reconstructing the low-mAs data of huge 
size. The image segmentation is the key component 
in ECC. The presence of PV effect and non-uniform 
fecal tagging render a very challenging task for 
image segmentation to preserve the details of the 
mucosa, where clinical information resides. While 
many segmentation algorithms are already reported, 
the MAP-EM (maximum a posteriori expectation-
maximization) segmentation of tissue mixtures in 
each image voxel shows the potential to mitigate 
the challenge (17). Since the PV layers are accurately 
identified, extraction of the colon wall mucosa 
becomes feasible. The preserved details on the 
mucosa layer by the MAP-EM mixture segmentation 
improve noticeably the detection of small polyps 
(10). Given the extracted volume of mucosa layer, 
more useful texture information can be available 
for development of CAD methods. This benefit for 
CAD development is already identified (18). Further 
improvement of CAD for small polyps should be 
expected when more useful texture information is 
extracted from the volumetric mucosa. In summary, 
low-dose CTC and/or high resolution MRC are likely 
to become a screening modality, supplement to oC 
to reduce colon cancer incidence rate. This is because 
of the following reasons: (i) both imaging modalities 
can generate high-quality abdominal volume image, 
including the entire colon, (ii) given the abdominal 
image from either imaging modality, extraction 
of the colon wall is a key operation to achieve high 
sensitivity and specificity by both the human and 
computer observers. The under-developing MAP-
EM segmentation of tissue mixtures has the potential 
to accurately identify the colon mucosa, from which 
an ECC pipeline can be built-up to cleanse the lumen 
and extract the wall.
CONCLuSION
Both oC and VC (i.e., CTC and MRC) ad-
vance toward the clinical needs as new technologies 
are developed and applied to overcome their draw-
backs. Each of these two methods plays a unique role 
for the goal of colon cancer prevention. oC will re-
main the choice for follow-up intervention and ther-
apeutic operation in the patients with symptoms and 
positive findings from other easy screening options. 
By its inherent invasive nature, oC will encounter 
competition from other less invasive modalities for 
the purpose of mass screening because of the high 
prevalence but preventive nature of the colon can-
cer. For screening purpose, VC has many advantag-
es over other options such as FoBT, FIT, stool DNA 
testing, and DCBE. Nowadays it is the most compet-
itive alternative method to oC for colon screening. 
The competition could lead to a good combination 
of VC screening with oC follow-up of the positive 
findings to reduce the incidence rate of this fatal dis-
ease (20). There are a few medical imaging modali-
ties currently available for VC, such as CT and MRI. 
As time goes on, other medical imaging modalities 
may become available for VC.
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